David Wohlberg
Managing Partner

David is a graduate of Yale Law School, where he was an editor of the Yale Law Journal, and a practicing corporate and securities lawyer. In addition to his legal practice, he has helped to finance, organize, manage and grow several startups and emerging growth companies. These companies have raised more than $400 million from individual investors and investment banks including Jefferies, Cowen, Piper Jaffray, Oppenheimer and Maxim.


David has previously served as president of a NASDAQ-listed immuno-oncology company, and is currently an officer and director of a private clinical-stage ophthalmology company developing treatments for rare retinal diseases.